{"id":482868,"title":"Consultation on the Prescription Drug List: Hydroquinone - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T20:07:49.404000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-prescription-drug-list-hydroquinone.html?wbdisable=true","snippet":"Consultation on the Prescription Drug List: Hydroquinone The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to add hydroquinone to the Prescription Drug List (PDL) when sold in a concentration greater than 2% in topical products.…","rawSnapshotUrl":"/api/snapshots/raw/482868","browseUrl":"https://replay.healtharchive.ca/job-6/20260106200749/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-prescription-drug-list-hydroquinone.html?wbdisable=true#ha_snapshot=482868","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}